VACH (VACH)

Voyager Technologies recently completed the acquisition of Astrobotic Technology, a specialist in lunar exploration systems, for approximately $300 million. This acquisition is highly synergistic, transforming Astrobotic into Voyager Lunar Systems and making Voyager a key player in lunar missions. Concurrently, Astrobotic, just before the acquisition, secured a significant $298 million contract from NASA to operate two lander missions as part of an ambitious project to build a long-term lunar base.

Appleby served as Cayman Islands legal counsel to Voyager Acquisition Corp. in its business combination with VERAXA Biotech AG, an innovative biopharmaceutical company focused on cancer therapies. The business combination was approved by shareholders in February and March 2026, and VERAXA's shares and warrants commenced trading on the Nasdaq Capital Market under the ticker symbols "VRXA" and "VRXAW" on June 11, 2026. Appleby's Mergers and Acquisition team, led by Partner Alexandra Low, advised on all Cayman Islands legal aspects of the transaction.

Voyager Acquisition Corp. (VACH) has delisted its Class A shares, warrants, and units from the Nasdaq Stock Market, as announced in an SEC Form 25-NSE filing. This action signifies a voluntary withdrawal following proper procedures by both VACH and Nasdaq, certifying compliance with 17 CFR 240.12d2-2. The delisting means these securities will no longer be traded on Nasdaq, impacting their visibility and liquidity for investors.

This article provides a stock quote for Voyager Acquisition Corp - Class A Ordinary Shares (VACH) on Nasdaq, showing its current price of 17.11 as of June 10, 2026. It also includes performance metrics, recent news on its business combination with VERAXA Biotech AG, and frequently asked questions about the company's public trading status and ticker symbol.